Syzygium cymosum
Syzygium cymosum · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Syzygium cymosum is a botanical species that has gained scientific interest due to its significant antimalarial potential. Research into this plant focuses primarily on the bioactive properties found within its leaves. Various preparations, including crude extracts, crude methanolic extracts, chloroform fractions, and specific fractionated portions, have been utilized to study its efficacy. These extracts demonstrate promising inhibitory activities against pathogens such as Malaria, Bacillus subtilis, E. coli K12, and Enteropathogenic E. coli. Consequently, this plant represents a valuable subject for investigating natural solutions to infectious diseases.
- Synonyms
- Calyptranthes Pollicina · Eugenia Cymosa · 6 more
- Common names
- Not available
- Family
- Myrtaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Syzygium cymosum is a distinctive plant species known by its common name, bois de pomme. This botanical identity reflects its unique characteristics and its place within its specific ecological niche. By understanding its common nomenclature, enthusiasts can more easily identify it in various natural landscapes. The relationship between its scientific classification and its local name highlights the rich linguistic history surrounding regional flora. Ultimately, recognizing the bois de pomme allows for a deeper appreciation of this specific member of the Syzygium genus.
Sources: Catalogue of Life (COL)
Synonyms
Syzygium cymosum is a complex species that has been classified under several different botanical names throughout history. Taxonomists have frequently associated it with various synonyms, including Calyptranthes pollicina and Eugenia cymosa. The plant's identity has also been linked to the specific variety Eugenia cymosa var. concinna. Furthermore, scientific literature identifies it through connections to Eugenia mascarensis and Eugenia nigrescens. Navigating these overlapping names is essential for accurately understanding the botanical relationships of this plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Syzygium cymosum is a distinguished member of the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. This plant belongs to the specific order Myrtales, showcasing its unique evolutionary lineage. It further falls under the family Myrtaceae, a group known for its diverse botanical characteristics. Finally, its identity is solidified by its placement within the genus Syzygium.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Myrtaceae |
| Genus | Syzygium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Syzygium cymosum is a notable plant species with a geographic range spanning several distinct regions. Its primary distribution is centered throughout Africa and the Western Indian Ocean. Beyond the mainland, the species can be found inhabiting the island of Mauritius. Additionally, its presence extends to the island of Réunion, further diversifying its ecological footprint. These widespread locations highlight the plant's ability to thrive across various island and continental environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Syzygium cymosum is a self-supporting plant that takes the form of a sturdy tree. It reaches a maximum height of 15 meters as it matures in its natural habitat. This impressive growth structure allows it to stand prominently within its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Syzygium cymosum has demonstrated significant antimalarial activity, marking a breakthrough in the study of this medicinal plant. Research shows that its leaves are traditionally used by healers in Bangladesh to treat malaria, a practice now supported by scientific investigation. In laboratory tests, crude methanolic extracts proved effective against various strains of Plasmodium falciparum, including those resistant to chloroquine and artemisinin. Furthermore, the plant's chloroform fraction exhibited particularly high potency, showing strong inhibitory effects against multiple parasite strains. These promising results suggest that S. cymosum could be a vital source for discovering novel antimalarial drug compounds.
Compounds
Conditions
Syzygium cymosum demonstrates significant therapeutic potential through its ability to treat various pathogenic organisms. When used to synthesize biogenic silver nanoparticles, the plant extract effectively treats the bacteria Bacillus subtilis, Escherichia coli K12, Escherichia coli DH5α, and Salmonella typhi. Additionally, the plant exhibits potent antimalarial properties capable of treating the chloroquine-resistant Plasmodium falciparum strain Dd2. These diverse biological activities highlight the plant's versatile efficacy against both bacterial and protozoan threats.
Preparations
Syzygium cymosum is prepared as a leaf extract to be used as a reducing agent for synthesizing biogenic silver nanoparticles. This plant is also prepared as a crude extract to investigate its potential antimalarial activity against various strains of Plasmodium falciparum. Researchers further processed the plant, which is prepared as a crude methanolic extract, to assess its cytotoxicity and selectivity. Additionally, Syzygium cymosum is prepared as fractionated portions to isolate more potent components. Among these, the plant is prepared as a chloroform fraction, which demonstrated the highest antimalarial activity against specific resistant strains.
Parts used
Syzygium cymosum possesses versatile biological properties that make its leaf an essential component in various medicinal applications. In traditional healing practices within malaria-endemic regions of Bangladesh, the leaves are utilized specifically for their potential to treat malaria. Recent scientific investigations have confirmed this by demonstrating that crude extracts from the leaves show promising antimalarial activity against multiple strains of Plasmodium falciparum. Furthermore, the leaf extract serves as an effective reducing agent in the green synthesis of biogenic silver nanoparticles, which exhibit strong antibacterial properties. These studies highlight the leaf's significant role as a source of bioactive compounds for both natural treatments and advanced nanotherapeutics.